BioTrove Installs First European RapidFire System at Boehringer Ingelheim and Obtains CE Mark for the Instrument
“RapidFire has allowed us to greatly streamline our workflow – our high-throughput screening of in vitro ADME samples is much faster using RapidFire than with our previous methods”, said Andreas Luippold, Lab Head (Department of Drug Discovery Support), Boehringer Ingelheim. “BioTrove’s RapidFire system will be an integral part of our drug discovery research helping us to focus our research efforts and resources on the best candidate compounds. Furthermore, the system helps us to be well prepared for future demands in the field of in vitro ADME.”
Intertek, the independent inspection and certification association, tested the RapidFire system and approved its application for the CE Mark, certifying the instrument meets European Union health, safety and environmental mandates. Intertek also recently awarded BioTrove the ETL Mark, indicating RapidFire meets North American product electrical safety standards and is now compliant to UL-61010-1, further extending the Company’s reach to Canada.
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!
Topic World Mass Spectrometry
Mass spectrometry enables us to detect and identify molecules and reveal their structure. Whether in chemistry, biochemistry or forensics - mass spectrometry opens up unexpected insights into the composition of our world. Immerse yourself in the fascinating world of mass spectrometry!